Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The global 23-Valent Pneumococcal Polysaccharide Vaccine market size is predicted to grow from US$ 1185 million in 2024 to US$ 2176 million in 2030; it is expected to grow at a CAGR of 10.7% from 2024 to 2030.
23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.
Market Drivers:
The 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) market is driven by the increasing prevalence of pneumococcal infections, particularly among high-risk populations such as the elderly, children, and immunocompromised individuals. Governments and health organizations worldwide are promoting vaccination programs to reduce the burden of pneumococcal diseases, which has significantly boosted market growth. Additionally, rising awareness about the importance of preventive healthcare and advancements in vaccine manufacturing technologies contribute to the increased adoption of PPSV23 vaccines.
Market Challenges:
However, the market faces challenges such as the high cost of vaccination, which limits accessibility in low- and middle-income countries. Moreover, the competition from newer pneumococcal conjugate vaccines (PCVs), which offer broader coverage and are preferred for pediatric use, poses a threat to PPSV23's market share. Another concern is vaccine hesitancy and misinformation, which can hinder immunization efforts and impact the overall market growth.
Merck is the largest manufacturers of 23-Valent pneumococcal polysaccharide vaccine in the world, has a share about 78%. Other players include Sinovac, Kangtai Bio, CDIBP, Walvax, etc. United States is dominating the global 23-Valent pneumococcal polysaccharide vaccine market, has a share nearly 78% in terms of production. The largest market is United States, holds a share about 48%, followed by China and Europe, with around 25% and 22% market share respectively.
LP Information, Inc. (LPI) ' newest research report, the “23-Valent Pneumococcal Polysaccharide Vaccine Industry Forecast” looks at past sales and reviews total world 23-Valent Pneumococcal Polysaccharide Vaccine sales in 2023, providing a comprehensive analysis by region and market sector of projected 23-Valent Pneumococcal Polysaccharide Vaccine sales for 2024 through 2030. With 23-Valent Pneumococcal Polysaccharide Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 23-Valent Pneumococcal Polysaccharide Vaccine industry.
This Insight Report provides a comprehensive analysis of the global 23-Valent Pneumococcal Polysaccharide Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 23-Valent Pneumococcal Polysaccharide Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global 23-Valent Pneumococcal Polysaccharide Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 23-Valent Pneumococcal Polysaccharide Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 23-Valent Pneumococcal Polysaccharide Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of 23-Valent Pneumococcal Polysaccharide Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global 23-Valent Pneumococcal Polysaccharide Vaccine market?
What factors are driving 23-Valent Pneumococcal Polysaccharide Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 23-Valent Pneumococcal Polysaccharide Vaccine market opportunities vary by end market size?
How does 23-Valent Pneumococcal Polysaccharide Vaccine break out by Type, by Application?
The global 23-Valent Pneumococcal Polysaccharide Vaccine market size is predicted to grow from US$ 1185 million in 2024 to US$ 2176 million in 2030; it is expected to grow at a CAGR of 10.7% from 2024 to 2030.
23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.
Market Drivers:
The 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) market is driven by the increasing prevalence of pneumococcal infections, particularly among high-risk populations such as the elderly, children, and immunocompromised individuals. Governments and health organizations worldwide are promoting vaccination programs to reduce the burden of pneumococcal diseases, which has significantly boosted market growth. Additionally, rising awareness about the importance of preventive healthcare and advancements in vaccine manufacturing technologies contribute to the increased adoption of PPSV23 vaccines.
Market Challenges:
However, the market faces challenges such as the high cost of vaccination, which limits accessibility in low- and middle-income countries. Moreover, the competition from newer pneumococcal conjugate vaccines (PCVs), which offer broader coverage and are preferred for pediatric use, poses a threat to PPSV23's market share. Another concern is vaccine hesitancy and misinformation, which can hinder immunization efforts and impact the overall market growth.
Merck is the largest manufacturers of 23-Valent pneumococcal polysaccharide vaccine in the world, has a share about 78%. Other players include Sinovac, Kangtai Bio, CDIBP, Walvax, etc. United States is dominating the global 23-Valent pneumococcal polysaccharide vaccine market, has a share nearly 78% in terms of production. The largest market is United States, holds a share about 48%, followed by China and Europe, with around 25% and 22% market share respectively.
LP Information, Inc. (LPI) ' newest research report, the “23-Valent Pneumococcal Polysaccharide Vaccine Industry Forecast” looks at past sales and reviews total world 23-Valent Pneumococcal Polysaccharide Vaccine sales in 2023, providing a comprehensive analysis by region and market sector of projected 23-Valent Pneumococcal Polysaccharide Vaccine sales for 2024 through 2030. With 23-Valent Pneumococcal Polysaccharide Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 23-Valent Pneumococcal Polysaccharide Vaccine industry.
This Insight Report provides a comprehensive analysis of the global 23-Valent Pneumococcal Polysaccharide Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 23-Valent Pneumococcal Polysaccharide Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global 23-Valent Pneumococcal Polysaccharide Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 23-Valent Pneumococcal Polysaccharide Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 23-Valent Pneumococcal Polysaccharide Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of 23-Valent Pneumococcal Polysaccharide Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Single Dose Vial
- Pre-filled Syringe
- For Children (Over 2 Years Old)
- For Adult
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Sinovac
- Kangtai Bio
- CDIBP
- Walvax
What is the 10-year outlook for the global 23-Valent Pneumococcal Polysaccharide Vaccine market?
What factors are driving 23-Valent Pneumococcal Polysaccharide Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 23-Valent Pneumococcal Polysaccharide Vaccine market opportunities vary by end market size?
How does 23-Valent Pneumococcal Polysaccharide Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for 23-Valent Pneumococcal Polysaccharide Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for 23-Valent Pneumococcal Polysaccharide Vaccine by Country/Region, 2019, 2023 & 2030
2.2 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
2.2.1 Single Dose Vial
2.2.2 Pre-filled Syringe
2.3 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
2.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2019-2024)
2.4 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
2.4.1 For Children (Over 2 Years Old)
2.4.2 For Adult
2.5 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
2.5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Breakdown Data by Company
3.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2019-2024)
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2019-2024)
3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company
3.4 Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Location Distribution
3.4.2 Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.4 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.5 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.6 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
5 AMERICAS
5.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
5.1.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024)
5.1.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024)
5.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024)
5.3 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
6.1.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2019-2024)
6.1.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2019-2024)
6.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024)
6.3 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine by Country
7.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024)
7.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024)
7.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024)
7.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine by Country
8.1.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024)
8.3 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
10.3 Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
10.4 Industry Chain Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
11.3 23-Valent Pneumococcal Polysaccharide Vaccine Customer
12 WORLD FORECAST REVIEW FOR 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE BY GEOGRAPHIC REGION
12.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Region
12.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Region (2025-2030)
12.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Type (2025-2030)
12.7 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.1.3 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Sinovac
13.2.1 Sinovac Company Information
13.2.2 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.2.3 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sinovac Main Business Overview
13.2.5 Sinovac Latest Developments
13.3 Kangtai Bio
13.3.1 Kangtai Bio Company Information
13.3.2 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.3.3 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Kangtai Bio Main Business Overview
13.3.5 Kangtai Bio Latest Developments
13.4 CDIBP
13.4.1 CDIBP Company Information
13.4.2 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.4.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 CDIBP Main Business Overview
13.4.5 CDIBP Latest Developments
13.5 Walvax
13.5.1 Walvax Company Information
13.5.2 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.5.3 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Walvax Main Business Overview
13.5.5 Walvax Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for 23-Valent Pneumococcal Polysaccharide Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for 23-Valent Pneumococcal Polysaccharide Vaccine by Country/Region, 2019, 2023 & 2030
2.2 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
2.2.1 Single Dose Vial
2.2.2 Pre-filled Syringe
2.3 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
2.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2019-2024)
2.4 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
2.4.1 For Children (Over 2 Years Old)
2.4.2 For Adult
2.5 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
2.5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Breakdown Data by Company
3.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2019-2024)
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2019-2024)
3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company
3.4 Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Location Distribution
3.4.2 Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.4 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.5 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.6 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
5 AMERICAS
5.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
5.1.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024)
5.1.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024)
5.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024)
5.3 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
6.1.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2019-2024)
6.1.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2019-2024)
6.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024)
6.3 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine by Country
7.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024)
7.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024)
7.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024)
7.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine by Country
8.1.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024)
8.3 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
10.3 Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
10.4 Industry Chain Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
11.3 23-Valent Pneumococcal Polysaccharide Vaccine Customer
12 WORLD FORECAST REVIEW FOR 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE BY GEOGRAPHIC REGION
12.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Region
12.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Region (2025-2030)
12.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Type (2025-2030)
12.7 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.1.3 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Sinovac
13.2.1 Sinovac Company Information
13.2.2 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.2.3 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sinovac Main Business Overview
13.2.5 Sinovac Latest Developments
13.3 Kangtai Bio
13.3.1 Kangtai Bio Company Information
13.3.2 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.3.3 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Kangtai Bio Main Business Overview
13.3.5 Kangtai Bio Latest Developments
13.4 CDIBP
13.4.1 CDIBP Company Information
13.4.2 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.4.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 CDIBP Main Business Overview
13.4.5 CDIBP Latest Developments
13.5 Walvax
13.5.1 Walvax Company Information
13.5.2 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.5.3 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Walvax Main Business Overview
13.5.5 Walvax Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Single Dose Vial
Table 4. Major Players of Pre-filled Syringe
Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale by Application (2019-2024) & (K Units)
Table 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Market Share by Application (2019-2024)
Table 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2019-2024) & ($ million)
Table 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company (2019-2024) & (K Units)
Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2019-2024) & ($ millions)
Table 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Producing Area Distribution and Sales Area
Table 21. Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
Table 22. 23-Valent Pneumococcal Polysaccharide Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (K Units)
Table 34. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 37. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 38. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2019-2024) & (K Units)
Table 39. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2019-2024)
Table 40. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 42. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 43. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (K Units)
Table 44. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 46. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 50. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 52. Key Market Challenges & Risks of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 53. Key Industry Trends of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 54. 23-Valent Pneumococcal Polysaccharide Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
Table 57. 23-Valent Pneumococcal Polysaccharide Vaccine Customer List
Table 58. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 59. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 61. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 63. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 65. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 69. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 71. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Merck Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 74. Merck 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Sinovac Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 79. Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Sinovac Main Business
Table 81. Sinovac Latest Developments
Table 82. Kangtai Bio Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 84. Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Kangtai Bio Main Business
Table 86. Kangtai Bio Latest Developments
Table 87. CDIBP Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 89. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. CDIBP Main Business
Table 91. CDIBP Latest Developments
Table 92. Walvax Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 94. Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Walvax Main Business
Table 96. Walvax Latest Developments
Table 1. 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Single Dose Vial
Table 4. Major Players of Pre-filled Syringe
Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale by Application (2019-2024) & (K Units)
Table 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Market Share by Application (2019-2024)
Table 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2019-2024) & ($ million)
Table 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company (2019-2024) & (K Units)
Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2019-2024) & ($ millions)
Table 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Producing Area Distribution and Sales Area
Table 21. Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
Table 22. 23-Valent Pneumococcal Polysaccharide Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (K Units)
Table 34. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 37. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 38. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2019-2024) & (K Units)
Table 39. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2019-2024)
Table 40. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 42. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 43. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (K Units)
Table 44. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 46. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 50. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 52. Key Market Challenges & Risks of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 53. Key Industry Trends of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 54. 23-Valent Pneumococcal Polysaccharide Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
Table 57. 23-Valent Pneumococcal Polysaccharide Vaccine Customer List
Table 58. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 59. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 61. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 63. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 65. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 69. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 71. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Merck Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 74. Merck 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Sinovac Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 79. Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Sinovac Main Business
Table 81. Sinovac Latest Developments
Table 82. Kangtai Bio Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 84. Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Kangtai Bio Main Business
Table 86. Kangtai Bio Latest Developments
Table 87. CDIBP Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 89. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. CDIBP Main Business
Table 91. CDIBP Latest Developments
Table 92. Walvax Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 94. Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Walvax Main Business
Table 96. Walvax Latest Developments
LIST OF FIGURES
Figure 1. Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 2. 23-Valent Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country/Region (2023)
Figure 10. 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Single Dose Vial
Figure 12. Product Picture of Pre-filled Syringe
Figure 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2023
Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2019-2024)
Figure 15. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For Children (Over 2 Years Old)
Figure 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Children (Over 2 Years Old) (2019-2024) & (K Units)
Figure 17. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For Adult
Figure 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Adult (2019-2024) & (K Units)
Figure 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Market Share by Application (2023)
Figure 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application in 2023
Figure 21. 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company in 2023 (K Units)
Figure 22. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company in 2023
Figure 23. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company in 2023 ($ millions)
Figure 24. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company in 2023
Figure 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region in 2023
Figure 27. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2019-2024 (K Units)
Figure 28. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2019-2024 ($ millions)
Figure 29. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2019-2024 (K Units)
Figure 30. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2019-2024 ($ millions)
Figure 31. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2019-2024 (K Units)
Figure 32. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2019-2024 ($ millions)
Figure 33. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2019-2024 ($ millions)
Figure 35. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2023
Figure 36. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2019-2024)
Figure 37. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Figure 38. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 39. United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 40. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 41. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 42. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 43. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2023
Figure 44. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2019-2024)
Figure 45. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Figure 46. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 47. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 48. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 49. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 50. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 51. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 52. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 53. China Taiwan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 54. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2023
Figure 55. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2019-2024)
Figure 56. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Figure 57. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 58. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 59. France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 60. UK 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 61. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 62. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 63. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2019-2024)
Figure 64. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 66. Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 67. South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 68. Israel 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 69. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 70. GCC Countries 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine in 2023
Figure 72. Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 73. Industry Chain Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 74. Channels of Distribution
Figure 75. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Forecast by Region (2025-2030)
Figure 76. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 2. 23-Valent Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country/Region (2023)
Figure 10. 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Single Dose Vial
Figure 12. Product Picture of Pre-filled Syringe
Figure 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2023
Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2019-2024)
Figure 15. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For Children (Over 2 Years Old)
Figure 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Children (Over 2 Years Old) (2019-2024) & (K Units)
Figure 17. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For Adult
Figure 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Adult (2019-2024) & (K Units)
Figure 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Market Share by Application (2023)
Figure 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application in 2023
Figure 21. 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company in 2023 (K Units)
Figure 22. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company in 2023
Figure 23. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company in 2023 ($ millions)
Figure 24. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company in 2023
Figure 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region in 2023
Figure 27. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2019-2024 (K Units)
Figure 28. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2019-2024 ($ millions)
Figure 29. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2019-2024 (K Units)
Figure 30. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2019-2024 ($ millions)
Figure 31. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2019-2024 (K Units)
Figure 32. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2019-2024 ($ millions)
Figure 33. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2019-2024 ($ millions)
Figure 35. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2023
Figure 36. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2019-2024)
Figure 37. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Figure 38. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 39. United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 40. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 41. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 42. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 43. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2023
Figure 44. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2019-2024)
Figure 45. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Figure 46. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 47. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 48. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 49. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 50. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 51. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 52. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 53. China Taiwan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 54. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2023
Figure 55. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2019-2024)
Figure 56. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Figure 57. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 58. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 59. France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 60. UK 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 61. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 62. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 63. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2019-2024)
Figure 64. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 66. Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 67. South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 68. Israel 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 69. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 70. GCC Countries 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine in 2023
Figure 72. Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 73. Industry Chain Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 74. Channels of Distribution
Figure 75. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Forecast by Region (2025-2030)
Figure 76. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2025-2030)
